BE Study of the Combinations of Gemigliptin 50mg and Metformin HCl Extended Release 500mg in Comparison to Each Component Administered Alone

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
This study is to evaluate the safety/tolerability and pharmacokinetics of the combinations of gemigliptin 50mg and metformin HCl extended release 500mg in comparison to each component administered alone in healthy male volunteers.
Epistemonikos ID: 93472cd3f68191ada0a22bfeaedfa1696ec7b485
First added on: May 10, 2024